AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Yu, DY Cringle, SJ Su, EN Yu, PK Jerums, G Cooper, ME
Citation: Dy. Yu et al., Pathogenesis and intervention strategies in diabetic retinopathy, CLIN EXP OP, 29(3), 2001, pp. 164-166

Authors: Gilbert, RE Akdeniz, A Allen, TJ Jerums, G
Citation: Re. Gilbert et al., Urinary transforming growth factor-beta in patients with diabetic nephropathy: implications for the pathogenesis of tubulointerstitial pathology, NEPH DIAL T, 16(12), 2001, pp. 2442-2443

Authors: Greive, KA Eppel, GA Reeve, S Smith, AI Jerums, G Comper, WD
Citation: Ka. Greive et al., Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats, AM J KIDNEY, 38(1), 2001, pp. 144-152

Authors: Jerums, G Allen, TJ Campbell, DJ Cooper, ME Gilbert, RE Hammond, JJ Raffaele, J Tsalamandris, C
Citation: G. Jerums et al., Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria, AM J KIDNEY, 37(5), 2001, pp. 890-899

Authors: Osicka, TM Yu, YX Lee, V Panagiotopoulos, S Kemp, BE Jerums, G
Citation: Tm. Osicka et al., Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery, CLIN SCI, 100(3), 2001, pp. 249-257

Authors: Jerums, G Cooper, ME Gilbert, RE Atkins, RC
Citation: G. Jerums et al., Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes, MED J AUST, 175(8), 2001, pp. 397-399

Authors: Osicka, TM Kiriazis, Z Pratt, LM Jerums, G Comper, WD
Citation: Tm. Osicka et al., Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats, DIABETOLOG, 44(2), 2001, pp. 230-236

Authors: Forbes, JM Soulis, T Thallas, V Panagiotopoulos, S Long, DM Vasan, S Wagle, D Jerums, G Cooper, ME
Citation: Jm. Forbes et al., Renoprotective effects of a novel inhibitor of advanced glycation, DIABETOLOG, 44(1), 2001, pp. 108-114

Authors: Shinada, M Akdeniz, A Panagiotopoulos, S Jerums, G Bach, LA
Citation: M. Shinada et al., Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy, J CLIN END, 85(3), 2000, pp. 1163-1169

Authors: Gilbert, RE Kelly, DJ Cox, AJ Wilkinson-Berka, JL Rumble, JR Osicka, T Panagiotopoulos, S Lee, V Hendrich, EC Jerums, G Cooper, ME
Citation: Re. Gilbert et al., Angiotensin converting enzyme inhibition reduces retinal overexpression ofvascular endothelial growth factor and hyperpermeability in experimental diabetes, DIABETOLOG, 43(11), 2000, pp. 1360-1367

Authors: Osicka, TM Houlihan, CA Chan, JG Jerums, G Comper, WD
Citation: Tm. Osicka et al., Albuminuria in patients with type 1 diabetes is directly linked to changesin the lysosome-mediated degradation of albumin during renal passage, DIABETES, 49(9), 2000, pp. 1579-1584

Authors: Osicka, TM Yu, YX Panagiotopoulos, S Clavant, SP Kiriazis, Z Pike, RN Pratt, LM Russo, LM Kemp, BE Comper, WD Jerums, G
Citation: Tm. Osicka et al., Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C, DIABETES, 49(1), 2000, pp. 87-93

Authors: Jenkins, MA Houlihan, C Ratnaike, S Jerums, G Parkin, JD
Citation: Ma. Jenkins et al., Measurement of iohexol by capillary electrophoresis: minimizing practical problems encountered, ANN CLIN BI, 37, 2000, pp. 529-536

Authors: Sasahara, T Jerums, G Nestel, P
Citation: T. Sasahara et al., Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects, NUTR MET CA, 9(1), 1999, pp. 19-24

Authors: Gilbert, RE Cox, AJ Kelly, DJ Wilkinson-Berka, JL Sage, EH Jerums, G Cooper, ME
Citation: Re. Gilbert et al., Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye, CONNECT TIS, 40(4), 1999, pp. 295

Authors: Youssef, S Nguyen, DT Soulis, T Panagiotopoulos, S Jerums, G Cooper, ME
Citation: S. Youssef et al., Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding, KIDNEY INT, 55(3), 1999, pp. 907-916

Authors: Soulis, T Sastra, S Thallas, V Mortensen, SB Wilken, M Clausen, JT Bjerrum, OJ Petersen, H Lau, J Jerums, G Boel, E Cooper, ME
Citation: T. Soulis et al., A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes, DIABETOLOG, 42(4), 1999, pp. 472-479

Authors: Houlihan, C Scott, A Jenkins, M Parkin, D Osicka, T Jerums, G
Citation: C. Houlihan et al., A comparison of the plasma disappearance of iohexol and Tc-99m-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes, AUST NZ J M, 29(5), 1999, pp. 693-700

Authors: Jerums, G
Citation: G. Jerums, Differences in renal outcomes with ACE inhibitors in type 1 and type 2 diabetic patients: Possible explanations, MIN ELECT M, 24(6), 1998, pp. 423-437
Risultati: 1-19 |